NCT06229470

Brief Summary

The purpose of this study is to evaluate the clinical utility of neurophysiological measurements of ECAP-controlled closed-loop SCS (i.e., neural panel metrics) to guide treatment of chronic pain of the trunk and/or limbs.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
250

participants targeted

Target at P75+ for not_applicable chronic-pain

Timeline
10mo left

Started Mar 2024

Typical duration for not_applicable chronic-pain

Geographic Reach
1 country

25 active sites

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress73%
Mar 2024Feb 2027

First Submitted

Initial submission to the registry

January 11, 2024

Completed
18 days until next milestone

First Posted

Study publicly available on registry

January 29, 2024

Completed
1 month until next milestone

Study Start

First participant enrolled

March 8, 2024

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 28, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 28, 2027

Last Updated

March 30, 2026

Status Verified

March 1, 2026

Enrollment Period

3 years

First QC Date

January 11, 2024

Last Update Submit

March 24, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in Evoked Compound Action Potentials (ECAPs) as measured by the Evoke SCS System

    physiological parameter to be measured = Evoked Compound Action Potentials (ECAPs); measurement tool = Evoke SCS System

    through 6-months post-implant

Secondary Outcomes (3)

  • Change in Visual Analogue Scale (VAS) Pain

    through 6-months post-implant

  • Change in PROMIS-29+2

    through 6-months post-implant

  • Change in PROMIS-10 Global Health

    through 6-months post-implant

Study Arms (1)

ECAP-Controlled, Closed-Loop SCS

EXPERIMENTAL

Spinal cord stimulation that measures and records evoked compound action potentials (ECAPs) and automatically adjusts the stimulation current to maintain a consistent ECAP amplitude.

Device: Evoke Spinal Cord Stimulation (SCS) System

Interventions

A spinal cord stimulation (SCS) system that measures and records evoked compound action potentials (ECAPs) and automatically adjusts the stimulation current to maintain a consistent ECAP amplitude.

ECAP-Controlled, Closed-Loop SCS

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Subject is planning to have a temporary trial with the Evoke System to aid in the management of chronic intractable pain of the trunk and/or limbs, including unilateral or bilateral pain associated with failed back surgery syndrome and/or intractable low back pain and leg pain.
  • Leg pain score ≥ 6 cm (Visual Analog Scale \[VAS\]).
  • Back pain score ≥ 6 cm (VAS).
  • Subject is able to speak, read, and/or understand English, willing and capable of giving informed consent, and able to comply with study-related requirements, procedures, and visits.
  • Subject is not pregnant and not \<18 years of age.

You may not qualify if:

  • N/A

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (25)

Lakeside Spine and Pain

Lake Havasu City, Arizona, 86403, United States

Location

Spanish Hills Interventional Pain Specialists

Camarillo, California, 93010, United States

Location

Pain Consultants of San Diego

La Mesa, California, 91942, United States

Location

Pacific Research Institute

Santa Rosa, California, 94104, United States

Location

Boomerang Healthcare

Walnut Creek, California, 94598, United States

Location

DBPS Research

Greenwood Village, Colorado, 80111, United States

Location

Pohlman Pain Associates

Delray Beach, Florida, 33445, United States

Location

Horizon Clinical Research

Jasper, Georgia, 30143, United States

Location

Rockford Pain Center

Rockford, Illinois, 61107, United States

Location

Goodman Campbell Brain and Spine

Carmel, Indiana, 46032, United States

Location

Metro Anesthesia & Pain Management

Des Moines, Iowa, 50317, United States

Location

Restorative Pain Institute

Louisville, Kentucky, 40241, United States

Location

Advanced Pain Institute

Hammond, Louisiana, 70403, United States

Location

Spine and Joint Institute

Glen Burnie, Maryland, 21061, United States

Location

Michigan Pain Specialists

Ann Arbor, Michigan, 48108, United States

Location

Pain Clinic of Michigan

Rochester Hills, Michigan, 48309, United States

Location

Tricity Research Center, LLC

Grand Island, Nebraska, 68803, United States

Location

Reno Tahoe Pain Associates

Reno, Nevada, 89509, United States

Location

Garden State Pain and Orthopedics

Clifton, New Jersey, 07013, United States

Location

Seaside Clinical Research Institute

Wilmington, North Carolina, 28412, United States

Location

Cleveland Clinic Foundation

Cleveland, Ohio, 44195, United States

Location

Premier Pain Treatment Institute

Loveland, Ohio, 45140, United States

Location

Carolinas Center for Advanced Management of Pain

Greenville, South Carolina, 29615, United States

Location

Institute of Precision Pain Medicine

Corpus Christi, Texas, 78414, United States

Location

Victoria Pain and Rehabilitation Center

Victoria, Texas, 77904, United States

Location

MeSH Terms

Conditions

Chronic Pain

Interventions

Spinal Cord StimulationDrug Delivery Systems

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Electric Stimulation TherapyTherapeuticsPhysical Therapy ModalitiesRehabilitationDrug Therapy

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 11, 2024

First Posted

January 29, 2024

Study Start

March 8, 2024

Primary Completion (Estimated)

February 28, 2027

Study Completion (Estimated)

February 28, 2027

Last Updated

March 30, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Locations